Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post-market, Prospective, Multi-center, Nonrandomized Study to Assess Posterolateral Lumbar Fusions Using FIBERGRAFT BG Matrix

NCT03884283 is registered in ClinicalTrials.gov with Prosidyan, Inc. as lead sponsor.

NCT NCT03884283
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03884283 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post-market, Prospective, Multi-center, Nonrandomized Study to Assess Posterolateral Lumbar Fusions Using FIBERGRAFT BG Matrix
Lead sponsor
Prosidyan, Inc.
Phase
Not applicable
Overall status
Completed
Start date
February 19, 2019
Completion date
May 21, 2023
Enrollment
102 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

degenerative disc disease, spinal stenosis lumbar, spondylolisthesis